Search results
BioNTech gets $145 million funding for African vaccine plants
WSAU Wausau· 7 days agoBy Ludwig Burger FRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 22 hours agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Thousands of cancer patients to trial personalised vaccines
BBC via Yahoo News· 5 days agoSo he signed up to a trial of an investigational vaccine made by German pharma company BioNTech,...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe vaccine being trialled utilises mRNA technology, similar to that of the Pfizer-BioNTech Covid-19 vaccine and is ...
Thousands of NHS patients to trial new personalised cancer vaccine in ‘landmark moment’
The Independent via Yahoo News· 5 days agoThe vaccine was created using mRNA technology – the same used inCovid jabs – and is being jointly...
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 2 days agoShares of Novavax (NASDAQ:NVAX) soared 11% in morning trade, after the documents were released. The...
Cancer vaccine hailed as 'game-changer'
Newsweek· 5 days agoCancer patients in the U.K. are about to get personalized cancervaccines as part of a new trial. Unlike vaccines for diseases like the flu or ...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 7 days agoThe updated monovalent XBB.1.5 COVID-19 vaccines were effective against Omicron subvariants circulating during the most recent respiratory virus season,...
NHS to give patients personalised cancer vaccines in world-first trials
The Telegraph via Yahoo News· 5 days agoNHS officials are in discussions with BioNTech and other pharmaceutical manufacturers about...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 5 days agoThe authors said the findings underscore the need for new boosters. Next week, the Center for...